Lataa...
Alpelisib-Induced Diabetic Ketoacidosis
Introduction: Alpelisib is a alpha-specific phosphoinositide 3-kinase inhibitor (PI3K) recently approved for patients with advanced or metastatic breast cancer with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, and activating mutations in the PIK3CA gene....
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089754/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.742 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|